Holomic is launching a Google Glass Platform for the measurement of rapid diagnostic tests (RDTs) and lateral flow immunoassays. Developed at the research lab of Professor Aydogan Ozcan at UCLA and licensed by Holomic, the Glass Platform is the first Glass diagnostic application to read RDTs for the real-time diagnosis and tracking of various diseases and health conditions.
Category Archives: Recent News
Holomic Director of R&D, Dr. Onur Mudanyali will give a talk on Holomic’s "Imaging-based rapid test and assay reader with trans-visual sensitivity" (Paper #: 9490-8) at SPIE DSS 2015, April 21-23 in Baltimore, MD. The talk will be a part of the Session on Advances in Global Health chaired by Jonathan D. Stallings, U.S....Read more
Holomic is expanding its portfolio of rapid test solutions with the debut of its fluorescent immunoassay reader, the HRDR-300, at the American Association of Clinical Chemistry (AACC) meeting in Chicago, July 28-31, 2014. Available in both portable Smartphone based or bench top versions, the HRDR-300 is a highly sensitive, low-cost fluorescent reader that uses patent...Read more
Holomic Director of R&D, Dr. Onur Mudanyali will present and exhibit at the AACC Emerging Clinical & Laboratory Diagnostics: The Portable Lab conference. Holomic’s abstract was selected among several submissions for an oral presentation at the event. Dr. Mudanyali’s oral presentation will take place on Thursday, April 24, 11:55 am-12:10 pm, in the session...Read more